Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017)

Fig. 1

Rates of resistant subsets (ESBL-positive, carbapenemase-negative; carbapenemase-positive, MBL-negative; and carbapenemase-positive, MBL-positive) among Enterobacterales isolates collected in the Asia–Pacific region (INFORM program, 2015–2017). ESBL, extended-spectrum β-lactamase; metallo-β-lactamase. Enterobacterales isolates (N = 7051) comprised: Citrobacter amalonaticus, 9; Citrobacter braakii, 22; Citrobacter farmeri, 8; Citrobacter freundii, 311; Citrobacter koseri, 231; Citrobacter murliniae, 1; Citrobacter sedlakii, 2; Enterobacter asburiae, 63; Enterobacter cloacae, 439; Enterobacter kobei, 22; Enterobacter ludwigii, 6; Enterobacter, non-speciated, 1; Escherichia coli, 2218; Klebsiella aerogenes, 287; Klebsiella oxytoca, 308; Klebsiella pneumoniae, 2082; Klebsiella variicola, 47; Morganella morganii, 164; Pluralibacter gergoviae, 6; Proteus hauseri, 56; Proteus mirabilis, 357; Proteus penneri, 7; Proteus vulgaris, 151; Providencia rettgeri, 61; Providencia stuartii, 65; Raoultella ornithinolytica, 5; Raoultella planticola, 1; Serratia liquefaciens, 2; Serratia marcescens, 118 and Serratia, non-speciated, 1. aCenters in Malaysia collected isolates in 2015 only

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us